Becker's Healthcare September 26, 2019
Alia Paavola

Consumer genetics company 23andMe is partnering with TrialSpark to help accelerate the pace, quality and experience of clinical trials, according to STAT.

The company plans to help match its customers with nearby study sites based on their disease, demographics and DNA.

The partnership comes as 23andMe moves into drug development, mining its database for therapeutic targets and entering research partnerships with drugmakers, universities and other nonprofits.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Precision Medicine, Technology
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article